Psilocybin + Placebo for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Feb 2018: Trial registered, NCT03429075
  2. 7 Jan 2019: Trial started, NCT03429075

The trials

NCT03429075: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms

State
Completed
Phase
Phase 2
People
59 taking part
Started
7 Jan 2019
Primary completion
17 Apr 2020
Arms
Psilocybin
Results
Posted on the registry
  1. 12 Feb 2018: Trial registered
  2. 7 Jan 2019: Trial started
  3. 17 Oct 2020: Trial completed
  4. 24 Oct 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.